Safety and Efficacy of Insulin Therapy Delivered via a 4mm Pen Needle in Obese Patients With Diabetes

Mayo Clinic Proceedings

Volumn 90, Issue 3, 2015, Pages 329-338

  Bergenstal, Richard M ^a   Strock, Ellie S ^a   Peremislov, Diana ^a   Gibney, Michael A ^b   Parvu, Valentin ^b   Hirsch, Laurence J ^b  

^a PARK NICOLLET CLINIC   (United States)

^b BD Technologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEVICE SAFETY; DRUG SAFETY; FEMALE; GLYCEMIC CONTROL; HOME CARE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHARMACEUTICAL EQUIVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS; MIDDLE AGED; NEEDLE; PATIENT SAFETY; TREATMENT OUTCOME; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-OVER STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NEEDLES; OBESITY; PATIENT SAFETY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 85027956563     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2014.12.014     Document Type: Article

References (32)

1. Cowie, C., Rust, K., Byrd-Holt, D., et al. Prevalence of diabetes and impaired fasting glucose in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 29:6 (2006), 1263–1268.
2. Flegal, K., Carroll, M., Kit, B., Ogden, C., Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307:5 (2012), 491–497.
3. Hu, F.B., Globalization of diabetes: the role of diet, lifestyle and genes. Diabetes Care 34:6 (2011), 1249–1257.
4. Cheng, Y.J., Imperatore, G., Geiss, L.S., et al. Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010. Diabetes Care 36:9 (2013), 2690–2696.
5. Hart, C.L., Hole, D.J., Lawlor, D.A., Davey Smith, G., How many cases of type 2 diabetes mellitus are due to being overweight in middle age? evidence from the Midspan prospective cohort studies using mention of diabetes mellitus on hospital discharge or death records. Diabet Med 24:1 (2007), 73–80.
6. Centers for Disease Control and Prevention (CDC). Prevalence of overweight and obesity among adults with diagnosed diabetes: United States, 1988-1994 and 1999-2002. MMWR Morb Mortal Wkly Rep 53:45 (2004), 1066–1068.
7. Hossain, P., Kawar, B., El Nahas, M., Obesity and diabetes in the developing world: a growing challenge. N Engl J Med 356:3 (2007), 213–215.
8. Conway, B., Miller, R.G., Costacout, T., et al. Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med 27:4 (2010), 398–404.
9. Centers for Disease Control and Prevention. 2014 National diabetes statistics report. http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.html. Accessed November 7, 2014.
10. De Coninck, C., Frid, A., Gaspar, R., et al. Results and analysis of the 2008-2009 Insulin Injection Technique Questionnaire survey. J Diabetes 2:3 (2010), 168–179.
11. Ludescher, B., Rommel, M., Willmer, T., Fritsche, A., Schick, F., Machann, J., Subcutaneous adipose tissue thickness in adults: correlation with BMI and recommendations for pen needle lengths for subcutaneous self-injection. Clin Endocrinol (Oxf) 75:6 (2011), 786–790.
12. Hirsch, L.J., Gibney, M.A., Albanese, J., et al. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Curr Med Res Opin 26:6 (2010), 1531–1541.
13. Schwartz, S., Hassman, D., Shelmet, J., et al. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus. Clin Ther 26:10 (2004), 1663–1678.
14. Kreugel, G., Keers, J.C., Kerstens, M.N., Wolffenbuttel, B.H., Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diabetes Technol Ther 13:7 (2011), 737–741.
15. Hirsch, L.J., Gibney, M.A., Li, L., Berube, J., Glycemic control, reported pain and leakage with a 4 mm x 32 G pen needle in obese and non-obese adults with diabetes: a post hoc analysis. Curr Med Res Opin 28:8 (2012), 1305–1311.
16. ® or high insulin doses: pre-specified subgroup analyses. Diabetes, 62(suppl 1), 2013, A255.
17. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane, W.V., Beck, R.W., Bode, B.W., et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359:14 (2008), 1464–1476.
18. Birkebaek, N.H., Solvig, J., Hansen, B., Jorgensen, C., Smedegaard, J., Christiansen, J.S., A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care, 31(9), 2008, e65.
19. Wittmann, A., Kover, J., Kralj, N., et al. Insulin leakage value in relation to pen needle length and administered dose after subcutaneous injection. Diabetes Technol Ther 12:8 (2010), 587–590.
20. Hofmann, P.L., Derraik, J.G., Pinto, T.E., et al. Defining the ideal injection techniques when using 5-mm needles in children and adults. Diabetes Care 33:9 (2010), 1940–1944.
21. Ignaut, D.A., Fu, H., Comparison of insulin diluent leakage postinjection using two different needle lengths and injection volumes in obese patients with type 1 or type 2 diabetes mellitus. J Diabetes Sci Technol 6:2 (2012), 389–393.
22. Miwa, T., Itoh, R., Kobayashi, T., et al. Comparison of the effects of a new 32-gauge x 4-mm pen needle and a 32-gauge x 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetes. Diabetes Technol Ther 14:12 (2012), 1084–1090.
23. Nagai, Y., Ohshige, T., Arai, K., et al. Comparison between shorter straight and thinner microtapered insulin injection needles. Diabetes Technol Ther 15:7 (2013), 550–555.
24. Hirose, T., Ogihara, T., Tozaka, S., Kanderian, S., Watada, H., Identification and comparison of insulin pharmacokinetics injected with a new 4-mm needle vs 6- and 8-mm needles, accounting for endogenous insulin and C-peptide secretion kinetics in non-diabetic adult males. J. Diabetes Invest 4:3 (2013), 287–296.
25. de la Pena, A., Yeo, K.P., Catton, E., Ignaut, D.A., Injection depth does not affect the pharmacokinetics or pharmacodynamics of insulin lispro in healthy obese or normal weight subjects. Diabetes, 63(suppl 1), 2014, A35.
26. Frid, A., Hirsch, L., Gaspar, G., et al. New injection recommendations for patients with diabetes. Diabetes Metab 36:suppl 2 (2010), S3–S18.
27. LoPresti, D., Ingegnosi, C., Strauss, K., Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection. Pediatr Diabetes 13:7 (2012), 525–533.
28. Gibney, M.A., Arce, C.H., Byron, K.J., Hirsch, L.J., Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 26:6 (2010), 1519–1530.
29. Hirsch, L., Byron, K., Gibney, M., Intramuscular risk at insulin injection sites: measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. Diabetes Technol Ther 16:12 (2014), 867–873.
30. Vaag, A., Handberg, A., Lauritzen, M., Henriksen, J.E., Pedersen, K.D., Beck-Nielsen, H., Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care 13 (1990), 74–76.
31. Vaag, A., Pedersen, K.D., Lauritzen, M., Hilderbrandt, P., Beck-Nielsen, H., Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diabet Med 7:4 (1990), 335–342.
32. Kramer, H., Cao, G., Dugas, L., Luke, A., Cooper, R., Durazo-Arvizu, R., Increasing BMI and waist circumference and prevalence of obesity among adults with Type 2 diabetes: the National Health and Nutrition Examination Surveys. J Diabetes Complications 24:6 (2010), 368–374.